Key Statistics
Market Cap$329.51M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$2.10
52W High$3.78
52W Low$0.99
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees156
Price Performance
1 Week+10.45%
3 Month+34.55%
1 Year+148.74%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$253.65M
Liabilities$17.45M
Net Income$67.67M loss
About
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of T-cell therapies designed for patients with B-cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze CABA with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.